Market Share of Cough Hypersensitivity Syndrome Treatment Industry
The market for cough hypersensitivity syndrome treatment is highly competitive and consists of several global as well as local players. Investment for the development of effective and long-acting products with lesser adverse effects and improving geographic penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market share. The major players include Johnson & Johnson, Bayer AG, GlaxoSmithKline plc, Pfizer, Novartis, AstraZeneca, and Teva Canada Limited.
Cough Hypersensitivity Syndrome Treatment Market Leaders
Johnson & Johnson
Bayer AG
Teva Canada Limited.
GlaxoSmithKline plc
Pfizer
*Disclaimer: Major Players sorted in no particular order